ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ARMANDO HINOJOSA M.D.

Internal Medicine

19,648

$1.09M

726
563 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

YONG CHANG MD

Internal Medicine

19,585

$1.67M

872
716 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$85
Average prescription price

Avg: $67

ANITA KURUVILLA M.D.

Internal Medicine

19,457

$921K

739
577 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$47
Average prescription price

Avg: $67

JAIME HERNANDEZ MD

Internal Medicine

19,332

$1.3M

819
667 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$67
Average prescription price

Avg: $67

DONA COOPER-DOCKERY MD

Internal Medicine

19,262

$1.87M

866
676 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$97
Average prescription price

Avg: $67

EDUARDO DEJESUS MD

Internal Medicine

19,234

$1.65M

895
739 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$86
Average prescription price

Avg: $67

RICHARD LE M.D.

Internal Medicine

19,189

$2.62M

715
559 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 27%

$137
Average prescription price

Avg: $67

RONALD KILLAM M.D.

Internal Medicine

19,070

$1.09M

616
373 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

JULIO SAVINON M.D., P.A.

Internal Medicine

19,070

$1.43M

1142
939 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $67

LISA DAVIS M.D.

Internal Medicine

19,036

$1.31M

793
591 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

RICARDO CUADRA MD

Internal Medicine

18,985

$1.08M

838
625 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

PAUL ANTHONY MD

Internal Medicine

18,937

$1.65M

1156
1085 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$87
Average prescription price

Avg: $67

AMY TINDOL M.D.

Internal Medicine

18,925

$955K

673
554 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

RICHARD ANDREWS DO

Internal Medicine

18,919

$1.27M

735
479 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$67
Average prescription price

Avg: $67

ROBERT CHING DO

Internal Medicine

18,907

$1.35M

697
454 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $67

RODRIGO SOTILLO MD

Internal Medicine

18,903

$1.31M

938
831 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

JEREMY HUFF D.O.

Internal Medicine

18,875

$1.06M

601
546 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

BLAS MIRANDA M.D.

Internal Medicine

18,797

$1.35M

1345
1097 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $67

NELSON KALAF MD

Internal Medicine

18,768

$1.71M

942
776 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$91
Average prescription price

Avg: $67

RAYMOND ACEBO MD

Internal Medicine

18,686

$1.13M

813
563 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $67

MARSHALL MORRISON M.D.

Internal Medicine

18,665

$1.04M

694
616 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

MANUEL MERCADO MD

Internal Medicine

18,496

$1.94M

801
655 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 27%

$105
Average prescription price

Avg: $67

LUIS REYNOSO MD

Internal Medicine

18,487

$1.63M

923
759 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$88
Average prescription price

Avg: $67

PIYUSH MITTAL MD

Internal Medicine

18,477

$1.03M

664
478 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

35%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

MICHAEL FLORES MD

Internal Medicine

18,473

$1.36M

579
417 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$74
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank